Skip to content
2000
Volume 11, Issue 12
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Wound healing is an intricate process requiring the concerted action of keratinocytes, fibroblasts, endothelial cells, and macrophages. Here, we review the literature on normal wound healing and the pathological forms of wound healing, such as hypertrophic or excessive scar formation, with special emphasis on the heme-heme oxygenase (HO) system and the versatile effector molecules that are formed after HO-mediated heme degradation. Excessive scar formation following wounding is thought to relate to prolonged oxidative and inflammatory stress in the skin. Evidence is accumulating that the heme-HO system forms a novel and important target in the control of wound healing. Heme-protein derived heme can act as a potent oxidative and inflammatory stress inducer, and excess levels of heme may thus contribute to delayed resolution of oxidative and inflammatory insults in the skin. This emphasizes the need for a timely reduction of the levels of heme. Heme-binding proteins, heme transporters, and the heme degrading protein, HO, form therefore a necessary defense. Deficiencies in these defense proteins or a disturbed redox status, as in diabetic patients, may render individuals more prone to heme-induced deleterious effects. A better understanding of the heme-heme oxygenase system as target during wound healing may result in novel strategies to reduce scar formation.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/138945010793178004
2010-12-01
2025-05-03
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/138945010793178004
Loading

  • Article Type:
    Research Article
Keyword(s): (myo)-fibroblasts; adenoviral gene transfer; alpha-smooth muscle actin (aSMA); alveolar bone; amelioration; aminolevulinate synthase (ALA-S); angiogenesis; angiopoietin-1; anionic carboxylate; apoptosis inducing factor (AIF); arachidonic acid (AA); atherosclerosis; biliverdin; biliverdin reductas; bleomycin; breast cancer resistance protein (ABCG2/BCRP); carbon monoxide (CO); chemokine; coagulation cascade; cyclo oxygenase (COX); cyclo-oxygenase (COX); death-inducing signaling complex (DISC); electron transport; endothelial cells; extracellular matrix (ECM); feline leukemia virus receptor C (FLVCR); fibroblast growth factors (FGFs); fibroblasts; fibronectin; glutathione-Stransferase; granulocytes; guanine-thymidine (GT); haptoglobin; haptoglobin-hemopexin (HpHx); Heme; Heme Binding Proteins; heme carrier protein 1 (HCP1); heme oxygenase; heme-heme oxygenase (HO); heme/porphyrin transport proteins; hemoglobin; hemoglobin (Hb); hemolysis; hemopexin; hemorrhage; holo-enzyme; homeostatic mechanisms; hyperbilirubinemic rats; hypertrophic scar; hypertrophic scars; hypertrophy; inflammation; inflammatory stress; insulin-like growth factor (IGF); iron chelators; iron protoporphyrin IX; keratinocyte growth factor (KGF); keratinocytes; leukocyte-adhesion cascade; lipophilic heme; macrophages; matrix metalloproteinase (MMPs); microenvironment; Microglobulin; mitochondrial outer membrane permeabilization (MOMP); molecular switch; myocardium; myoglobin; neovascularization; nitric oxide synthase (NOS); Ornithine; pathogenesis; plasma proteins; proliferative phase; reactive oxygen species (ROS); remodeling phase; rheumatoid arthritis; scar formation; splenectomized; stromal cell derived factor-1 (SDF-1); systemic sclerosis patients (SSC); Toll-like receptor molecule-4 (TLR-4); transforming growth factor-β (TGFβ); tumor necrosis factor (TNF); vascular endothelial growth factor (VEGF); wound healing
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test